What Happened?
Raleigh, NC-based Pathalys Appointed Greg Klatt as Vice President of Finance
About the Company
Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of end stage kidney disease (ESKD). Pathalys` initial asset is upacicalcet, a novel calcimimetic with the potential to improve the treatment of SHPT in hemodialysis patients. Beyond upacicalcet, Pathalys continues to identify other high priority needs and potential solutions for patients with ESKD. Pathalys is headquartered in Research Triangle Park, North Carolina.
About the Person
Greg Klatt is Vice President of Finance at Pathalys. Previously, Greg held various senior HR leadership roles in the industry.
Info Source
News
Short Profile